Long‐term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo‐controlled, phase 3 QUAZAR AML‐001 trial. Issue 4 (6th February 2023) - Wei, Andrew H.; Döhner, Hartmut; Sayar, Hamid; Ravandi, Farhad; Montesinos, Pau; Dombret, Hervé; Selleslag, Dominik; Porkka, Kimmo; Jang, Jun‐Ho; Skikne, Barry; Beach, C. L.; Prebet, Thomas; et al.